We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FMS vs. OFIX: Which Stock Should Value Investors Buy Now?
Read MoreHide Full Article
Investors interested in Medical - Instruments stocks are likely familiar with Fresenius (FMS - Free Report) and Orthofix (OFIX - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Fresenius has a Zacks Rank of #1 (Strong Buy), while Orthofix has a Zacks Rank of #3 (Hold) right now. Investors should feel comfortable knowing that FMS likely has seen a stronger improvement to its earnings outlook than OFIX has recently. But this is only part of the picture for value investors.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
FMS currently has a forward P/E ratio of 10.64, while OFIX has a forward P/E of 25.59. We also note that FMS has a PEG ratio of 0.51. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. OFIX currently has a PEG ratio of 2.56.
Another notable valuation metric for FMS is its P/B ratio of 0.84. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, OFIX has a P/B of 1.07.
Based on these metrics and many more, FMS holds a Value grade of B, while OFIX has a Value grade of C.
FMS sticks out from OFIX in both our Zacks Rank and Style Scores models, so value investors will likely feel that FMS is the better option right now.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
FMS vs. OFIX: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Fresenius (FMS - Free Report) and Orthofix (OFIX - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Fresenius has a Zacks Rank of #1 (Strong Buy), while Orthofix has a Zacks Rank of #3 (Hold) right now. Investors should feel comfortable knowing that FMS likely has seen a stronger improvement to its earnings outlook than OFIX has recently. But this is only part of the picture for value investors.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.
FMS currently has a forward P/E ratio of 10.64, while OFIX has a forward P/E of 25.59. We also note that FMS has a PEG ratio of 0.51. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. OFIX currently has a PEG ratio of 2.56.
Another notable valuation metric for FMS is its P/B ratio of 0.84. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, OFIX has a P/B of 1.07.
Based on these metrics and many more, FMS holds a Value grade of B, while OFIX has a Value grade of C.
FMS sticks out from OFIX in both our Zacks Rank and Style Scores models, so value investors will likely feel that FMS is the better option right now.